Based on this evidence, we investigated the TSP1-to-PLT ratio to explore its variations during obesity progression and its potential relevance as a biomarker of cardiometabolic risk. The gene discussed is NAAA; the disease is obesity due to melanocortin 4 receptor deficiency.